Global Telepharmacy Market Size (2024 - 2029)

The telepharmacy market is projected to experience significant growth over the forecast period, driven by factors such as increased smartphone usage, technological advancements, and greater internet penetration. The COVID-19 pandemic played a crucial role in boosting the market by facilitating remote pharmaceutical services, which helped reduce hospital admissions and infectious exposures. Additionally, the market's expansion is supported by strategic business initiatives and research funding from key industry players. Despite these positive trends, the lack of regulation on telepharmacy services may pose challenges to market growth.

Market Size of Global Telepharmacy Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Telepharmacy Market Size
Study Period 2019 - 2029
Market Size (2024) USD 10.80 Billion
Market Size (2029) USD 27.36 Billion
CAGR (2024 - 2029) 20.42 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Telepharmacy Market Top Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Telepharmacy Market Analysis

The Global Telepharmacy Market size is estimated at USD 10.80 billion in 2024, and is expected to reach USD 27.36 billion by 2029, growing at a CAGR of 20.42% during the forecast period (2024-2029).

COVID-19 pandemic had a substantial impact on patients with any diseases, telepharmacy helped the patient to combat its effect. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in the boost of telepharmacy market along with balancing the strain on the healthcare system globally. In wake of the COVID-19 outbreak, telepharmacy is improving public health along with decreasing the potential of infectious exposures.

As per an article published in April 2022 titled 'Survey of the patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy' in the National Library of Medicine, survey data indicated that about 77% of respondents preferred appointments via telepharmacy while 23% preferred in-person services due to reducing the incidence of contagious disease, spending less time receiving pharmaceutical services, reducing cost, traveling a shorter distance for receiving pharmaceutical services and saving time among other reasons.

As per an article published in January 2022 titled 'Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic' in the Europepmc, the patient group that had access to telepharmacy service have reduced the rise in hospitalization rates versus the group without access to the telepharmacy service. Thus, the COVID-19 outbreak had a positive impact on telepharmacy market. Also, the telepharmacy market is expected to grow due to the significant increase in the use of smartphones globally.

Further, increasing technological advancement, increasing internet penetration, and growing awareness regarding telepharmacy is among the major factors driving the growth of the studied market. With the growing advancements in technology, telecommunication is being utilized in every field these days. As per an article published in January 2021, the internet penetration rate in the world is at 59%, 7% high as compared to Q1 of 2020.

In addition, business strategic initiatives and funding for research and development by major players in the market are positively affecting the studied market. For instance, in June 2022 CPS Solutions announced it has closed its acquisition of Trellis Rx, LLC , they will together offer a broader range of services, structure, better support to patients, health and hospital systems alike. Additionally, in January 2021 Intalere announces a new agreement with One Touch Telehealth. Intalere members will receive negotiated pricing on One Touch Telehealth's entire suite of telehealth solutions. Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

However, the lack of regulation on services is likely to impede the market growth.

Telepharmacy Industry Segmentation

As per the scope of the report, In telepharmacy a pharmacist utilizes telecommunications technology to provide patient-care services. telepharmacy involves drug review and monitoring, dispensing prescription-based drugs, therapy management, patient counseling, clinical consultation, and outcomes assessment among others. The telepharmacy market is expected to register a CAGR of 25.3% over the forecast period. The telepharmacy market is segmented By Services (Patient Counseling, Remote Dispensing, Drug Therapy Monitoring, Refill Authorization for Prescription Drugs), By Delivery Mode (On-premises, Web-based, Cloud-based) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Services
Patient Counseling
Remote Dispensing
Drug Therapy Monitoring
Refill Authorization for Prescription Drugs
By Delivery Mode
On-premises
Web-based
Cloud-based
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Telepharmacy Market Size Summary

The telepharmacy market is poised for significant growth, driven by the increasing adoption of digital health solutions and advancements in technology. The COVID-19 pandemic acted as a catalyst, enhancing the market's expansion by necessitating remote healthcare services to mitigate the spread of the virus. This shift has led to a preference for telepharmacy services among patients, as they offer convenience, reduced exposure to infectious diseases, and cost savings. The market's growth is further supported by the rising penetration of smartphones and the internet, which facilitate access to telepharmacy services, especially in remote areas. Strategic initiatives and collaborations among key industry players are also contributing to the market's development, as they expand service offerings and improve patient support systems.

North America is expected to lead the telepharmacy market due to its advanced technological infrastructure and high awareness of health services. The region's growth is bolstered by the presence of numerous market players and innovative product launches. Despite the market's fragmented nature, with several companies operating globally and regionally, the focus on research and development remains a priority for major players. However, challenges such as the lack of regulatory frameworks for telepharmacy services could impede market growth. Overall, the telepharmacy market is anticipated to experience robust expansion, driven by technological advancements, strategic partnerships, and increasing consumer preference for remote healthcare solutions.

Explore More

Global Telepharmacy Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Driver

      1. 1.2.1 Increasing Technological Advancement

      2. 1.2.2 Increasing Internet Penetration

      3. 1.2.3 Growing Awareness Regarding the Telepharmacy

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Regulations on Services

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Services

      1. 2.1.1 Patient Counseling

      2. 2.1.2 Remote Dispensing

      3. 2.1.3 Drug Therapy Monitoring

      4. 2.1.4 Refill Authorization for Prescription Drugs

    2. 2.2 By Delivery Mode

      1. 2.2.1 On-premises

      2. 2.2.2 Web-based

      3. 2.2.3 Cloud-based

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Telepharmacy Market Size FAQs

The Global Telepharmacy Market size is expected to reach USD 10.80 billion in 2024 and grow at a CAGR of 20.42% to reach USD 27.36 billion by 2029.

In 2024, the Global Telepharmacy Market size is expected to reach USD 10.80 billion.

Telepharmacy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)